Qiyu Biotech
Qiyu Biotech is an innovative macromolecular drug developer.
Launch date
Market cap
-
Enterprise valuation
AUD170—255m (Dealroom.co estimates Dec 2021.)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Series A | |
* | CNY200m | Series B | |
Total Funding | AUD42.5m |